2023³â Áß¾Ó´ëÇб³º´¿ø ºñ´¢À¶ÇÕ ¹× ¿À°¡³ëÀÌµå ¼¼¹Ì³ª ¿¬¼öÆòÁ¡ ½Åû : 2023-11-10
±³À°ÀÏÀÚ : 2023-11-10
±³À°Àå¼Ò : Á߾Ӵ뱤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦
±³À°ÁÖÁ¦ : 2023³â Áß¾Ó´ëÇб³º´¿ø ºñ´¢À¶ÇÕ ¹× ¿À°¡³ëÀÌµå ¼¼¹Ì³ª ¿¬¼öÆòÁ¡ ½Åû
ÁÖÃÖ±â°ü : Áß¾Ó´ëÇб³º´¿ø
´ã´çÀÚ : ±èÀºÁÖ
¿¬¶ôó : 02-6299-2796
À̸ÞÀÏ : app@app2010.com
±³À°Á¾·ù : ºñ´¢ÀÇÇаú
Âü¼®¿¹»óÀÎ : 50¸í
Èñ¸ÁÆòÁ¡ : 2Á¡
Áö¿ª : °æ±âµµ
±³À°½Ã°£ : 5 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í "»çÀüµî·Ï À̸ÞÀϷθ¸ °¡´É / 11¿ù3ÀϱîÁö
app@app2010.com"
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11¿ù 10ÀÏ Á߾Ӵ뱤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦ 11:00~11:10 Anti-cancer effects of sonodynamic therapy in bladder cancer ÃÖ¼¼¿µ(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 11¿ù 10ÀÏ Á߾Ӵ뱤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦ 11:10~11:20 Bladder cancer and lactobacillus ¸Í¼¼Á¤(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 11¿ù 10ÀÏ Á߾Ӵ뱤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦ 11:20~11:30 Efficacy of recombinant dltA ÀåÀÎÈ£(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 11¿ù 10ÀÏ Á߾Ӵ뱤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦ 11:30~11:40 ¹æ±¤³» ÁÖÀÔ¿ë ¼±Ãµ¸é¿ªÈ¸ÇÇ À¯ÀüÀÚ ÀçÁ¶ÇÕ Ç×¾Ï ¹ÙÀÌ·¯½º Á¦ÀÛ ¹× ¹æ±¤¾Ï Ç×¾Ï È¿°ú ÃøÁ¤ À±¾Æ¸§(ÇѾç´ë)
Åä·Ð 11¿ù 10ÀÏ Á߾Ӵ뱤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦ 11:40~12:00 Discussion ( )
±³À°½Ã°£ 11¿ù 10ÀÏ Á߾Ӵ뱤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦ 12:00~12:10 Development of a Metastatic Renal Cell Carcinoma Mouse and Biomimetic Organ-on-a-Chip Model by Renca-luc Cell ÃÖÁß¿ø(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 11¿ù 10ÀÏ Á߾Ӵ뱤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦ 12:10~12:20 Intrafemoral Injection of Luciferase tagged Hormone Sensitive Prostate Cancer Cell Lines to Establish a Bone Metastatic Prostate Cancer Animal Model ÅÂÁ¾Çö(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 11¿ù 10ÀÏ Á߾Ӵ뱤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦ 12:20~12:30 Stone animal model ±èÁ¤ÈÆ(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 11¿ù 10ÀÏ Á߾Ӵ뱤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦ 12:30~12:40 ü³»ÀÇ »ý¸®Àû ¹°¸® Çö»óÀ» ±¸ÇöÇÑ ¸ÖƼ ½ºÄÉÀÏ ¹æ±¤ ¸ð»ç ½Ã½ºÅÛ ¹ÚÁß¿(Áß¾Ó´ë)
Åä·Ð 11¿ù 10ÀÏ Á߾Ӵ뱤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦ 12:40~13:00 Discussion ( )
±³À°½Ã°£ 11¿ù 10ÀÏ Á߾Ӵ뱤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦ 13:30~13:40 »ÀÀüÀ̸𵨸µ Ĩ ±èÁ¤¾Æ(°úÇбâ¼ú¿¬ÇÕ´ëÇпø´ëÇб³)
±³À°½Ã°£ 11¿ù 10ÀÏ Á߾Ӵ뱤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦ 13:40~13:50 Áٱ⼼Æ÷ Ä¡·áÁ¦ È¿À² ÃÖÀûÈ ÀÌÇöÁ¤(Áß¾Ó´ë)
±³À°½Ã°£ 11¿ù 10ÀÏ Á߾Ӵ뱤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦ 13:50~14:00 À¯ÀüÀÚ °¡À§ ±â¹Ý À¯ÀüÁúȯ Ä¡·áÁ¦ Á¶Çö¿(±¹¹Î´ë)
Åä·Ð 11¿ù 10ÀÏ Á߾Ӵ뱤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦ 14:00~14:20 Discussion ( )
±³À°½Ã°£ 11¿ù 10ÀÏ Á߾Ӵ뱤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦ 14:20~14:30 ºòµ¥ÀÌÅÍ Åë°è ¿¬±¸ ÀÌÁÖ¿µ(Áß¾Ó´ë)
±³À°½Ã°£ 11¿ù 10ÀÏ Á߾Ӵ뱤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦ 14:30~14:40 ¸ÞŸºÐ¼® ¿¬±¸ ¾çÀ±Á¤(°¡Å縯°üµ¿´ë)
Åä·Ð 11¿ù 10ÀÏ Á߾Ӵ뱤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦ 14:40~15:00 Discussion ( )
±³À°½Ã°£ 11¿ù 10ÀÏ Á߾Ӵ뱤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦ 15:20~15:30 Patient derived ovarian cancer organoid Que Thanh Thanh Nguyen(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 11¿ù 10ÀÏ Á߾Ӵ뱤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦ 15:30~15:40 ½ÇÇè¼³°è¹ý°ú Á¢ÇÕÈÇÐÀ» ±â¹ÝÀ¸·Î ÇÑ »õ·Î¿î ¼¼Æ÷Åõ°úÆéŸÀ̵åÀÇ ¼³°è ¹× ÀÀ¿ë¿¡ °üÇÑ ÅëÇÕÀû ¿¬±¸ ÀÌ»ó±æ(Áß¾Ó´ë)
±³À°½Ã°£ 11¿ù 10ÀÏ Á߾Ӵ뱤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦ 15:40~15:50 ¸¸´ÉÁٱ⼼Æ÷ ±â¹Ý ÄáÆÏ¿À°¡³ëÀ̵å Á¤¹Ð ºÐÈ ºÐ¼® ¹× °íÈ¿À² ¾à¹° µ¶¼º/È¿´É Æò°¡¿ë ¿À°¡³ëÀ̵åĨ ±èÅÂÇü(Áß¾Ó´ë)
Åä·Ð 11¿ù 10ÀÏ Á߾Ӵ뱤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦ 15:50~16:00 Discussion ( )
±³À°½Ã°£ 11¿ù 10ÀÏ Á߾Ӵ뱤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦ 16:00~16:10 ¼Òº¯ ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È °Ë»ç¿Í ÀÌÇØ ¼ÛÁÖ¼±(GCÁö³ð)
±³À°½Ã°£ 11¿ù 10ÀÏ Á߾Ӵ뱤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦ 16:10~16:20 ¿ä·Î°á¼® °ü·Ã ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ÇÑÇöÈ£(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 11¿ù 10ÀÏ Á߾Ӵ뱤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦ 16:20~16:30 º´¿ø ±â¹Ý Àΰ£ ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ¿¬±¸ ¼³¿ìÁØ(Áß¾Ó´ë)
Åä·Ð 11¿ù 10ÀÏ Á߾Ӵ뱤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦ 16:30~16:50 Discussion ( )